Holen Sie sich die Stockscreener-App
14.07
6.80%
0.91
Handel nachbörslich:
13.98
-0.09
-0.64%
Schlusskurs vom Vortag:
$13.16
Offen:
$12.74
24-Stunden-Volumen:
1.28M
Relative Volume:
0.77
Marktkapitalisierung:
$662.55M
Einnahmen:
$217.11M
Nettoeinkommen (Verlust:
$-651.19M
KGV:
-1.0831
EPS:
-12.99
Netto-Cashflow:
$-387.26M
1W Leistung:
-5.16%
1M Leistung:
+40.41%
6M Leistung:
+68.12%
1J Leistung:
+93.06%
1-Tages-Spanne:
$12.44
$14.52
1-Wochen-Bereich:
$12.44
$17.58
52-Wochen-Spanne:
$5.00
$17.58
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Firmenname
Ginkgo Bioworks Holdings Inc
Sektor
Branche
Telefon
(877) 442-5362
Adresse
27 DRYDOCK AVENUE, BOSTON
Vergleichen Sie DNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
14.07 | 800.38M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-15 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-05-10 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-06-02 | Herabstufung | Goldman | Neutral → Sell |
| 2023-05-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | Eingeleitet | Berenberg | Buy |
| 2022-10-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2022-02-23 | Eingeleitet | Goldman | Neutral |
| 2022-02-01 | Eingeleitet | BofA Securities | Neutral |
| 2022-01-28 | Eingeleitet | BofA Securities | Buy |
| 2022-01-07 | Eingeleitet | BTIG Research | Buy |
| 2021-11-29 | Eingeleitet | Jefferies | Buy |
| 2021-10-13 | Eingeleitet | Raymond James | Outperform |
| 2021-10-12 | Eingeleitet | William Blair | Outperform |
| 2021-09-20 | Eingeleitet | HSBC Securities | Buy |
Alle ansehen
Ginkgo Bioworks Holdings Inc Aktie (DNA) Neueste Nachrichten
Custom watchlist performance reports with Ginkgo Bioworks Holdings Inc.Insider Selling & Weekly Return Optimization Plans - newser.com
Advanced analytics toolkit walkthrough for Ginkgo Bioworks Holdings Inc.Earnings Performance Report & Low Risk Entry Point Tips - newser.com
Is Ginkgo Bioworks Holdings Inc. still worth holding after the dipJuly 2025 Final Week & Free Weekly Chart Analysis and Trade Guides - newser.com
Visual trend scoring systems applied to Ginkgo Bioworks Holdings Inc.July 2025 Closing Moves & High Accuracy Swing Entry Alerts - newser.com
How Ginkgo Bioworks Holdings Inc. Class stock behaves in tightening cyclesExit Point & Reliable Price Breakout Alerts - newser.com
Is Ginkgo Bioworks Holdings Inc. stock oversold or undervaluedPortfolio Gains Report & Long Hold Capital Preservation Plans - newser.com
How sentiment analysis helps forecast Ginkgo Bioworks Holdings Inc.2025 Market Overview & Free Accurate Trade Setup Notifications - newser.com
Ginkgo Bioworks Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Has Ginkgo Bioworks Holdings Inc. found a price floorGlobal Markets & Consistent Profit Trading Strategies - newser.com
Ginkgo Bioworks (NYSE:DNA) Sets New 12-Month HighTime to Buy? - MarketBeat
Will Ginkgo Bioworks Holdings Inc. Class stock benefit from sector leadershipJuly 2025 EndofMonth & Reliable Price Action Trade Plans - newser.com
Can Ginkgo Bioworks Holdings Inc. stock outperform in 2025 bull market2025 Growth vs Value & Free Community Supported Trade Ideas - newser.com
Looking at the Narrative for Ginkgo Bioworks After Recent Analyst and Strategy Updates - Yahoo Finance
Weiss Ratings Reaffirms Sell (D-) Rating for Ginkgo Bioworks (NYSE:DNA) - MarketBeat
Ginkgo Bioworks Holdings, Inc. (DNA) Registers a Bigger Fall Than the Market: Important Facts to Note - sharewise.com
Using AI based signals to follow Ginkgo Bioworks Holdings Inc.Portfolio Growth Summary & Long-Term Investment Growth Plans - newser.com
Ginkgo Bioworks Holdings Inc. stock chart pattern explained2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Can Ginkgo Bioworks Holdings Inc. Class stock resist broad market declinesJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com
Ginkgo Bioworks (NYSE:DNA) Trading 14.8% HigherStill a Buy? - MarketBeat
Ginkgo Bioworks (NYSE:DNA) Shares Down 4.1% Following Insider Selling - MarketBeat
Why Ginkgo Bioworks Holdings Inc. stock could benefit from AI revolutionJuly 2025 Update & Real-Time Chart Pattern Alerts - newser.com
Do Lower Revenue Projections Reveal a Strategic Pivot for Ginkgo Bioworks (DNA)? - Sahm
Will Ginkgo Bioworks Holdings Inc. stock reach Wall Street targetsJuly 2025 Action & Daily Profit Focused Stock Screening - newser.com
Ginkgo Bioworks Holdings, Inc. (DNA) Outpaces Stock Market Gains: What You Should Know - MSN
Ginkgo Bioworks (NYSE:DNA) Insider Sells $84,135.00 in Stock - MarketBeat
How to monitor Ginkgo Bioworks Holdings Inc. with trend dashboardsMarket Activity Report & Reliable Volume Spike Alerts - newser.com
Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) Shares Climb 45% But Its Business Is Yet to Catch Up - simplywall.st
Risk vs reward if holding onto Ginkgo Bioworks Holdings Inc.2025 Retail Activity & Stepwise Trade Execution Plans - newser.com
Forbes J M & Co. LLP Sells 17,323 Shares of Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Finanzdaten der Ginkgo Bioworks Holdings Inc-Aktie (DNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):